MedPlus Subsidiary Faces Temporary Drug License Suspension in Telangana

MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has provided an update.

MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received a two-day suspension order for a drug license at one of its stores in Telangana. This suspension, issued by the Assistant Director of Drugs Control Administration, is due to violations under the Drugs and Cosmetics Act, 1940, and is expected to result in a potential revenue loss of approximately Rs 1.43 lacs, impacting the company’s financial operations.

More about MedPlus Health Services Ltd.

MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and health services. The company is based in Hyderabad, India, and serves a significant market in the region through its network of stores.

Average Trading Volume: 21,140

Technical Sentiment Signal: Buy

Current Market Cap: 96.85B INR

For an in-depth examination of MEDPLUS stock, go to TipRanks’ Overview page.